Ac immune presents full phase 1b results on anti-abeta vaccine and discusses its first-in-class diagnostic for parkinson's disease at aaic 2021

Aci-24 generated an encouraging immune response that correlated with a signal of target engagement in patients with down syndrome (ds)

ACIU Ratings Summary

ACIU Quant Ranking